Related Experiment Video
Updated: Sep 14, 2025

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
Fucoidan modification for stable melatonin O/W emulsions: Interfacial structure and properties
Yanan Zhao1, Yitong Wang1, Fei Yu1
1College of Food Science and Technology, Guangdong Ocean University, Guangdong Provincial Key Laboratory of Aquatic Product Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Guangdong Provincial Engineering Technology Research Center of Seafood, Key Laboratory of Advanced Processing of Aquatic Product of Guangdong Higher Education Institution, Zhanjiang 524088, China.
This study modified fucoidans (FUCs) with 2-Octen-1-ylsuccinic anhydride (OSA) and ultrasound, creating a stable emulsion for melatonin delivery. The optimized fucoidan emulsion enhanced melatonin
Area of Science:
- Food Science and Technology
- Materials Science
- Biochemistry
Background:
- Fucoidans (FUCs) are polysaccharides with potential emulsifying properties.
- Modifying fucoidans can enhance their functionality for delivery systems.
- Melatonin is a bioactive compound with limited bioavailability.
Purpose of the Study:
- To investigate the effects of 2-Octen-1-ylsuccinic anhydride (OSA) modification and ultrasound on fucoidan (FUC) structure and emulsification.
- To develop a stable polysaccharide emulsion system for enhanced melatonin delivery.
- To evaluate the impact of the emulsion on melatonin bioaccessibility and release kinetics.
Main Methods:
- Fucoidans were modified using 2-Octen-1-ylsuccinic anhydride (OSA).
- Ultrasound treatment was applied to the modified fucoidan emulsions.
- Interfacial tension, droplet size, and storage stability were measured.
- Melatonin bioaccessibility and free fatty acid (FFA) release were assessed.
Main Results:
- OSA modification and ultrasound improved fucoidan amphiphilicity and reduced interfacial tension.
- 9%-OSA-FUCs emulsions treated with 400 W ultrasound exhibited the smallest droplet size (1.34 ± 0.03 μm).
- The emulsion system significantly enhanced melatonin bioaccessibility (55.32%) and delayed FFA release.
Conclusions:
- Rational modification of fucoidans with OSA and ultrasound creates highly stable emulsions.
- This delivery system effectively protects melatonin from the gastrointestinal environment, improving absorption.
- The findings offer insights for designing functional polysaccharide-based emulsifiers and delivery systems for hydrophobic compounds.
Related Concept Videos
Membrane Fluidity
Colloids
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

